Nav: Home

Science Current Events and Science News | Brightsurf | June 03, 2018


ASCO18: Trial shows how PET scans help tailor therapy for esophageal cancer
Survival results for the CALGB 80303 Trial presented at ASCO18 show that PET scan may determine which esophageal cancer patients should continue first chemotherapy and who should switch.
Is exercise associated with lower risk of death for adult survivors of childhood cancer?
Vigorous exercise is associated with reductions in the risk of death among adult survivors of childhood cancer.
ASCO: ALEX trial results show alectinib further outpacing crizotinib in ALK+ NSCLC
Updated data presented at ASCO 2018 further consolidate alectinib as the standard-of-care for first-line treatment of ALK+ non-small cell lung cancer.
ASCO18: Updated Phase 1 results of crizotinib against MET-amplified lung cancer
By lowering the bar for 'high MET amplification,' a study suggests that crizotinib may benefit more MET-amplified non-small cell lung cancer patients than previously thought.
Economic models significantly underestimate climate change risks
Policymakers are being misinformed by the results of economic models that underestimate the future risks of climate change impacts, according to a new journal paper by authors in the United States and the United Kingdom, which is published June 4, 2018.
Landmark study finds more breast cancer patients can safely forgo chemotherapy
A 21-gene test performed on tumors could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study published in the New England Journal of Medicine.
A filthy first -- the 6 common types of disgust that protect us from disease revealed
Poor hygiene, animals or insects carrying disease and risky sexual behavior are among the distinct kinds of disgust that can help us to avoid disease and infection, according to new research published in a special issue of the Philosophical Transactions of the Royal Society.
Erdafitinib shows promise in urothelial cancer patients with specific mutations
In an international Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with the oral FGFR inhibitor erdafitinib (ERDA) was well-tolerated and achieved a robust response for patients with metastatic urothelial, or urinary tract, cancers harboring mutations in the FGFR3 gene.
Study shows taking aspirin before or after coronary
New research presented at this year's Euroanaesthesia congress in Copenhagen, Denmark shows that in patients undergoing a coronary artery bypass graft (CABG) surgery, taking aspirin before and after surgery is associated with an 18 percent to 34 percent reduced mortality risk after four years.
A sense of disgust in bonobos?
Kyoto University researchers investigate the adaptive system of disgust in bonobos to further understand the origins of it in humans.
Study reveals hypnosedation as an effective alternative to general anesthesia for various surgeries
New research presented at this year's Euroanaesthesia congress in Copenhagen, Denmark shows that hypnosedation is a valuable alternative to conventional general anesthesia.
Why do some sleep-deprived people experience worse cognitive functioning than others?
The key to predicting how someone is affected by sleep loss may be found in microRNAs (miRNAs), according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Forced court appearances make cops more tired, generate more citizen complaints
Results from a new study conducted by researchers at Washington State University and Central Queensland University suggest that complaints against US police officers increase when they work consecutive night shifts.

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

The Next Frontier
Colonizing Mars or more distant planets seems like science fiction. But becoming a spacefaring species may be in our near future. This hour, TED speakers on living beyond Earth--and whether we should. Guests include NASA Chief Scientist James Green, science writer Stephen Petranek, MIT Media Lab researcher Lisa Nip, and astronomer Lucianne Walkowicz.
Now Playing: Science for the People

#508 Freedom's Laboratory
This week we're looking back at where some of our modern ideas about science being objective, independent, and apolitical come from. We journey back to the Cold War with historian and writer Audra Wolfe, talking about her newest book "Freedom's Laboratory: The Cold War Struggle for the Soul of Science".